Insulet Corp

PODD: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
PF&LOCK|?&WWLOCK|<Q$<ZYb

Insulet Earnings: Solid Quarterly Results Give Way to Impending Deceleration in Second Half

Insulet posted second-quarter constant-currency revenue growth of 23% and an operating margin of 16%, down 330 basis points from the prior-year period, largely due to rising SG&A expense. Management trimmed its 2026 outlook on a softer expected second half, with weakness concentrated in the US.

Sponsor Center